Pervasip Sees 25% Yield Improvement Ahead of Schedule from Partnership with Premier Cultivation Group

SEATTLE, WASHINGTON, June 30, 2022 (GLOBE NEWSWIRE) -- Pervasip Corp. (OTC: PVSP) (“Pervasip” or the “Company”), a developer of companies and technologies in high value emerging markets, and Zen Asset Management (“ZAM”), its wholly owned subsidiary today announced that its partnership with Full Spectrum Advisors is yielding results ahead of expectations.

Following announcements made in March, introducing its partnership with Full Spectrum Advisors, Pervasip reports early results that are exceeding projected yield improvements with 25% increased harvest results in the cultivation centers growing Artizen flower.

While the upgrades to all facilities are still only 40% completed, cultivators are already reporting materially increased harvest weights and flower quality. Tremendous work conducted by all stakeholders is showing and validating the path Pervasip embarked on in Q4 of 2021.

“Our independent cultivators, utilizing our facilities, are ecstatic about the early results of this first round of changes and upgrades” said German Burtscher, the company’s President & CEO. “We already see substantial increases not only in harvest yields but also flower quality stemming from a combination of improved genetic diversity and updated grow SOPs. The Company is well on its way to realize the $5 million in additional annual revenue from the tremendous work that got launch late last year.”

Pervasip Corporation
Pervasip Corp., a developer of companies and technologies in high value emerging markets, owns Artizen Corporation and its subsidiary, Zen Asset Management LLC, a diversified asset management company founded to acquire, develop, and support companies and technologies in the cannabis industry. ZAM’s existing clients operate four licensed cannabis cultivation and one processing facility in Washington. Most of the biomass produced by these independent cultivators has been sold historically under the Artizen brand, including all-time top selling products in flower in Washington state. Additional information on Artizen-branded products is available online at www.artizencannabis.com. Pervasip additionally owns 5% of KRTL Biotech, Inc., a developer of biotechnologies with a focus on pharmaceutical applications of cannabinol and psilocybin. Additional information on KRTL is available online at www.krtlbiotech.com. Additional information on Pervasip can be found at www.pervasip.net.